A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma

Angela Zaladonis, Jeffrey Farma, Maureen Hill, Meghan Hotz, Karli Meller, Tamsin Board, Mengying Deng, Hong Wu, Sanjay Reddy, Eileen O'Halloran

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Tumor infiltrating lymphocytes (TILs) and regression are thought to be distinct markers of the immune response to melanoma. Objective: This study sought to analyze the relationship of TIL grade and presence of regression to each other and to other prognostic histopathologic and clinical values in melanoma. Materials and Methods: A retrospective analysis was conducted using patients diagnosed with melanoma between 2013 and 2019 whose complete histopathologic reports were available. Results: Regression was seen in 48.9%, 30.1% and 37.9% of patients with brisk, non-brisk, and absent TILs respectively (P=0.019). Melanoma tumors with brisk TILs were found to have a lower Breslow thickness than those with non-brisk or absent (P= 0.001). Tumors with regression were also found to have lower Breslow thickness (P<0.001). Neither TIL grade nor regression were protective of nodal metastasis or associated with improved survival. Conclusion: Brisk TILs have a positive association with thinner tumors and the presence of tumor regression relative to non-brisk or absent TILs. This may suggest a more robust immune response in tumors with brisk TILs. Further exploration of the interplay between TIL grade, lymphocyte cell subtype and lymphocyte density may help explain this finding.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalJournal of Surgical Research
Volume267
DOIs
StatePublished - Nov 2021

Keywords

  • Humans
  • Lymphocytes, Tumor-Infiltrating
  • Melanoma/pathology
  • Prognosis
  • Retrospective Studies
  • Skin Neoplasms/pathology

Fingerprint

Dive into the research topics of 'A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma'. Together they form a unique fingerprint.

Cite this